The Market Online Video

HotCopper Highlights, Week 12: Core Lithium is back! But is demand? Elsewhere – NOVONIX, West Wits & more!

Greetings and welcome to HotCopper Highlights for Week 12 of 2026, I’m Jon Davidson, in this segment the stocks and company announcements you were watching
A Coles storefront.

Week 12 CY26, Wrapped: Iran knocks XJO -8%; Morgan Stanley sees oil shock killer for ASX; Coles hints at hikes

As I write this I am on a train getting ready to race back to my apartment to back a bag to jump

Well below US$5K/oz, gold’s surefire status as a safe haven has shifted

In the post-COVID-19 world, it’s almost definitely news to nobody reading this that gold prices have staged a fairly historic run.
Hong Kong coastline drone shot

Paradigm Biopharma activates Hong Kong trial site for Phase III osteo trial for iPPS

Paradigm Biopharmaceuticals (ASX:PAR) has kicked off the screening process for participants with osteoarthritis ahead of the company’s Hong Kong-based
Doctor at SNT

Existing myleofibrosis drugs can make the condition worse. Syntara Ltd could be about to change that 

In the face of a new war crisis weighing heavily on both equities and economics alike, value hunters (both long- and short-term minded
The Market Online Video

The ASX Today: Yesterday, I told you the worst was over. That turned out to be a lie. Sorry!

Greetings and welcome to HotCopper’s The ASX Today for Thursday of Week 12, I’m Jon Davidson, and right when I thought we might have seen the
3D model of a brain concept

Some 80% of people who develop Parkinson’s present with this sleep disorder first. Syntara’s treating it

Syntara has today added ~$2 million to its coffers – $1.7M to be exact – after…

Heading into CYQ2, Magnum keeps eyes on drilling as auger campaign fires up

Magnum M&E has its eyes on a whopping 10,000-metre auger drill run on-site at its newly…
The Market Online Video

ASX Today: Gold hasn’t done anything in 5 days, suggesting markets don’t see catalyst either

Greetings and welcome to HotCopper’s The ASX Today for Wednesday of Week 12, I’m Jon Davidson, and it looks like we could be in for another
Nasal spray

Two days after Tetratherix moves to GLP-1 nasal drugs, HSBC analysts say thematic overhyped

After announcing it'd be moving into the GLP-1 weight loss drugs space, Tetratherix has dropped as…